AIDA Syringe Color Labeling Device helps meet ISMP Guidelines
Mistakes with medications pose a significant risk in Ambulatory Surgical Centers and Hospitals. These errors typically stem from the intricate nature of care, frequent handoffs, a fast-paced environment, and issues related to medications. To mitigate these risks, the Institute for Safe Medication Practices (ISMP) has created guidelines aimed at enhancing medication safety in these environments, with the goal of mitigating and preventing such errors.
AIDATM Syringe Color Labeling Device serves as a valuable tool in complying with ISMP Guidelines, particularly focusing on key elements #4 and #10.
AIDA’s AI camera identifies medications by scanning their barcodes, offering an electronic “double-check” to guarantee that the chosen medication aligns with the intended one. Subsequently, the system automatically generates a TJC (The Joint Commission) –compliant, easily readable label that adheres to ASA (American Society of Anesthesiologists) guidelines. This process eliminates the necessity for manual handwriting, thereby ensuring safety, accuracy, and compliance.
In anesthesia alone, it is estimated that medication errors occur in at least 1 out of every 133 doses administered. 1-2
In the pursuit of enhancing medication safety, ISMP collaborated with clinical experts, professional organizations, and industry leaders to formulate best practice guidelines spanning all stages of perioperative care. The 2022 Guidelines, developed through this collaborative effort, are now accessible to hospitals, ambulatory surgery centers, and other procedural settings. They aim to fill recognized national gaps in perioperative and procedural medication safety, serving as a foundation and support for additional implementation efforts to decrease adverse patient events.
Here is how AIDATM helps you to comply with ISMP guidelines.
| ISMP Guideline 4.3 | Eliminate the use of handwritten labels in perioperative/procedural areas by 2025. |
| ISMP Guideline 4.4 | Include a machine-readable code (e.g. barcode, radio frequency identification [RFID]) on all syringe and infusion labels, including those that are PRACTITIONER-PREPARED, by 2025. |
| ISMP Guideline 4.5 | Label PRACTITIONER-PREPARED syringes of medications with, at the minimum, the full name, concentration/dose of the drug, name or initials of the preparing practitioner, as well as an expiration date (when not used in 24 hours), and time (if expiration occurs in less than 24 hours). Application of an anesthesia color-coded drug class label alone is not sufficient. |
| ISMP Guideline 10.11 | Use machine-readable coding (e.g. BARCODE SCANNING, RFID) in preoperative/preprocedural and postoperative/postprocedural settings to verify patients and medications/solutions prior to administration. |
| ISMP Guideline 10.12 | Take steps to implement machine-readable coding (e.g. BARCODE SCANNING, RFID) in intraoperative/intraprocedural workflows to confirm medication/solution selection prior to administration. |
| ISMP Targeted Medication Safety Best Practices for Hospitals 2022/2023 Best Practice 18 | Maximize the use of barcode verification prior to medication and
vaccine administration by expanding use beyond inpatient care areas |